Immunology of endometriosis

Immunology and Allergy Clinics of North America

Volumn 22, Issue 3, 2002, Pages 585-598

  Lebovic, Dan I ^a,b   Mueller, Michael D ^a,c   Hornung, Daniela ^a,d   Taylor, Robert N ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; RANTES; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

CELLULAR IMMUNITY; ENDOMETRIOSIS; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSURVEILLANCE; LEUKOCYTE ADHERENCE; NONHUMAN; PELVIS; PERITONITIS; PRIORITY JOURNAL; REVIEW;

EID: 0036694440     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(02)00007-3     Document Type: Review

References (93)

1. Sampson JA. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927;14:422-9.
2. Halme J, Hammond M, Hulka J, et al. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 1984;64:151-4.
3. Kruitwagen RF, Poels LG, Willemsen WN, et al. Endometrial epithelial cells in peritoneal fluid during the early follicular phase. Fertil Steril 1991;55:297-303.
4. Evers JLH. The defense against endometriosis. Fertil Steril 1996;66:351-3.
5. Witz CA, Montoya-Rodriguez IA, Miller DM, et al. Mesothelium expression of integrins in vivo and in vitro. J Soc Gynecol Investig 1998;5:87-93.
6. Van der Linden PJQ, de Goeij AF, Dunselman GA, et al. Endometrial cell adhesion in an in vitro model using intact amniotic membranes. Fert Steril 1996;65:76-80.
7. Nisolle M, Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 1997;68:585-96.
8. Witz CA, Thomas MR, Montoya-Rodriguez IA, et al. Short-term culture of peritoneum explants confirms attachment of endometrium to intact peritoneal mesothelium. Fertil Steril 2001;75: 385-90.
9. Kennedy S. The genetics of endometriosis. Eur J Obstet Gynecol Reprod Biol 1999;82:129-33.
10. Wheeler JM, Malinak LR. Recurrent endometriosis. Contrib Gynecol Obstet 1987; 16:13-21.
11. DeCherney AH. Endometriosis: recurrence and retreatment. Clin Ther 1992;14:766-72.
12. Anderson DJ. The importance of mucosal immunology to problems in human reproduction. J Reprod Immunol 1996;31:3-19.
13. Salamonsen LA, Lathbury LJ. Endometrial leukocytes and menstruation. Hum Reprod Update 2000;6:16-27.
14. McMaster M, Lim K-H, Taylor RN. Immunobiology of human pregnancy. Curr Prob Obstet Gynecol Fertil 1998;21:7-23.
15. Dunselman GA, Hendrix MG, Bouckaert PX, et al. Functional aspects of peritoneal macrophages in endometriosis of women. J Reprod Fertil 1988;82:707-10.
16. Oosterlynck DJ, Cornillie FJ, Waer M, et al. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fert Steril 1991;56:45-51.
17. Isaacson KB, Coutifaris C, Garcia CR, et al. Production and secretion of complement component 3 by endometriotic tissue. J Clin Endocrinol Metab 1989;69:1003-9.
18. Kauma S, Clark MR, White C, et al. Production of fibronectin by peritoneal macrophages and concentration of fibronectin in peritoneal fluid from patients with or without endometriosis. Obstet Gynecol 1988;72:13-8.
19. Hill JA, Anderson DJ. Lymphocyte activity in the presence of peritoneal' fluid from fertile women and infertile women with and without endometriosis. Am J Obstet Gynecol 1989;161: 861-4.
20. Fakih H, Baggett B, Holtz G, et al. Interleukin-1: a possible role in the infertility associated with endometriosis. Fertil Steril 1987;47:213-7.
21. Mori H, Sawairim M, Nakagawa M. Peritoneal fluid interleukin-1β and tumor necrosis factor in patients with benign gynecologic disease. Am J Reprod Immunol 1991;26:62-7.
22. Keenan J, Chen T, Chadwell N. IL-1β, TNF-α, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am J Reprod Immunol 1995;34:381-5.
23. Mori H, Sawairi M, Nakagawa M, et al. Expression of interleukin-1 (IL-1) β messenger ribonucleic acid (mRNA) and IL-1 receptor antagonist mRNA in peritoneal macrophages from patients with endometriosis. Fertil Steril 1992;57:535-42.
24. Bergqvist A, Bruse C, Carlberg M, et al. Interleukin 1β, interleukin-6, and tumor necrosis factor-β in endometriotic tissue and in endometrium. Fertil Steril 2001;75:489-95.
25. Lebovic DI, Bentzien F, Chao VA, et al. Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1β. Mol Hum Reprod 2000;6:269-75.
26. Lebovic DI, Baldocchi RA, Mueller MD, et al. Endometriosis genomics: altered expression of a cell-cycle suppressor gene, Tob, in endometriotic cells by cDNA array analyses [abstract]. J Soc Gynecol Invest 2001;8:70A.
27. Viganò P, Gaffuri B, Somigliana E, et al. Expression of intercellular adhesion molecule (ICAM)-1 mRNA and protein is enhanced in endometriosis versus endometrial stromal cells in culture. Mol Hum Reprod 1998;4:1150-6.
28. Tabibzadeh SS, Santhanam U, Sehgal PB, et al. Cytokine-induced production of IFN-β 2/IL-6 by freshly explanted human endometrial stromal cells: modulation by estradiol-17 β. J Immunol 1989;142:3134-9.
29. Laird SM, Li TC, Bolton AE. The production of placental protein 14 and interleukin 6 by human endometrial cells in culture. Hum Reprod 1993;8:793-8.
30. Zarmakoupis PN, Rier SE, Maroulis GB, et al. Inhibition of human endometrial stromal cell proliferation by interleukin 6. Hum Reprod 1995;10:2395-9.
31. Rier SE, Zarmakoupis PN, Hu X, et al. Dysregulation of interleukin-6 responses in ectopic endometrial stromal cells: correlation with decreased soluble receptor levels in peritoneal fluid of women with endometriosis. J Clin Endocrinol Metab 1995;80:1431-7.
32. Koyama N, Matsuura K, Okamura H. Cytokines in the peritoneal fluid of patients with endometriosis. Int J Gynecol Obstet 1993;43:45-50.
33. Buyalos R, Funari VA, Azziz R, et al. Elevated interleukin-6 levels in peritoneal fluid of patients with pelvic pathology. Fertil Steril 1992;58:302-6.
34. Keenan JA, Chen TT, Chadwell NL, et al. Interferon-γ (IFN-γ) and interleukin-6 (IL-6) in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am J Reprod Immunol 1994;32:180-3.
35. Taylor RN, Ryan IP, Moore ES, et al. Angiogenesis and macrophage activation in endometriosis. Ann N Y Acad Sci 1997;828:194-207.
36. Pellicer A, Albert C, Garrido N, et al. The pathophysiology of endometriosis-associated infertility: follicular environment and embryo quality. J Reprod Fertil 2000;55(suppl):109-19.
37. Rier SE, Parsons AK, Becker JL. Altered interleukin-6 production by peritoneal leukocytes from patients with endometriosis. Fertil Steril 1994;61:294-9.
38. Tseng JF, Ryan IP, Milam TD, et al. Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metab 1996;81:1118-22.
39. Braun DP, Gebel H, House R, et al. Spontaneous and induced synthesis of cytokines by peripheral blood monocytes in patients with endometriosis. Fertil Steril 1996;65:1125-9.
40. Ortiz D, Krensky A, Nelson P. Kinetics of transcription factors regulating the RANTES chemokine gene reveal a developmental switch in nuclear events during T-lymphocyte maturation. Mol Cell Biol 1996;16:202-10.
41. Hornung D, Ryan IP, Chao VA, et al. Immunolocalization and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells. J Clin Endocrinol Metab 1997;82:1621-8.
42. Ryan IP, Tseng JF, Schriock ED, et al. RANTES chemokine expression is up-regulated in stromal cells cultured from human endometriosis tissues [abstract]. J Soc Gynecol Invest 1996; 3:74A.
43. Khorram O, Taylor RN, Ryan IP, et al. Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. Am J Obstet Gynecol 1993;169:1545-9.
44. Akoum A, Lemay A, Bronet C, et al. Cytokine-induced secretion of monocyte chemotactic protein-1 by human endometriotic cells in culture. Am J Obstet Gynecol 1995;172:594-600.
45. Homung D, Bentzien F, Wallwiener D, et al. Chemokine bioactivity of RANTES in endometriotic and normal endometrial stromal cells and peritoneal fluid. Mol Hum Reprod 2001;7: 163-8.
46. Arima K, Nasu K, Narahara H, et al. Effects of lipopolysaccharide and cytokines on production of RANTES by cultured human endometrial stromal cells. Mol Hum Reprod 2000;6:246-51.
47. Lebovic DI, Mueller MD, Taylor RN. Vascular endothelial growth factor in reproductive biology. Curr Opin Obstet Gynecol 1999;11:255-60.
48. Philippeaux MM, Piguet PF. Expression of tumor necrosis factor-α. and its mRNA in the endometrial mucosa during the menstrual cycle. Am J Path 1993;143:480-6.
49. Hunt J, Chen H, Hu X. Tumor necrosis factor-α, messenger ribonucleic acid and protein in human endometrium. Biol Reprod 1992;47:141-7.
50. Laird SM, Tuckerman EM, Saravelos H, et al. The production of tumour necrosis factor α (TNF-α) by human endometrial cells in culture. Hum Reprod 1996;11:1318-23.
51. Chen D, Yang Z, Hilsenrath R. Stimulation of prostaglandin (PG) F2 α and PGE2 release by tumor necrosis factor-α and interleukin-1 α. in cultured human luteal phase endometrial cells. Hum Reprod 1995;10:2773-80.
52. Zhang R-J, Wild RA, Ojago J. Effect of tumor necrosis factor-alpha on adhesion of human endometrial stromal cells to peritoneal mesothelial cells: an in vitro system. Fertil Steril 1993; 59:1196-201.
53. Eisermann J, Gast MJ, Pineda J, et al. Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery. Fertil Steril 1988;50:573-9.
54. Donnez J, Smoes P, Gillerot S, et al. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998;13:1686-90.
55. Ferrara N, Houck KA, Jakeman LB, et al. The vascular endothelial growth factor family of polypeptides. J Cell Biochem 1991;47:211-8.
56. D'Angelo G, Struman I, Martial J, et al. Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proc Natl Acad Sci U S A 1995;92:6374-8.
57. Gille H, Kowalski J, Yu L, et al. A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3′-kinase activation and endothelial cell migration. EMBO J 2000;19:4064-73.
58. Torry DS, Holt VJ, Keenan JA, et al. Vascular endothelial growth factor expression in cycling human endometrium. Fertil Steril 1996;66:72-80.
59. Shifren JL, Tseng JF, Zaloudek CJ, et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996;81:3112-8.
60. Li XF, Gregory J, Ahmed A. Immunolocalization of vascular endothelial growth factor in human endometrium. Growth Factors 1994;11:277-82.
61. Mueller MD, Vigne JL, Minchenko A, et al. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors α and β. Proc Natl Acad Sci U S A 2000;97: 10972-7.
62. Charnock-Jones DS, Sharkey AM, Rajput-Williams J, et al. Identification and localization of alternately spliced mRNA's for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod 1993;48:1120-8.
63. Shweiki D, Itin A, Neufeld G, et al. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 1993;91:2235-43.
64. Brogi E, Wu T, Namiki A. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994;90:649-52.
65. Ben-Av P, Crofford LJ, Wilder L, et al. Induction of vascular endothelial growth factor in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett 1995;372:83-7.
66. Nisolle M, Casanas-Roux F, Anaf V, et al. Morphometric study of the stromal vascularization in peritoneal endometriosis. Fertil Steril 1993;59:681-4.
67. McLaren J, Prentice A, Chamock-Jones DS, et al. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest 1996;98:482-9.
68. Conover A, Hintz RL, Rosenfeld RG. Direct evidence that the insulin receptor mediates a mitogenic response in cultured human fibroblasts. Horm Metab Res 1989;21:59-63.
69. Oyamada I, Palka J, Schalk EM, et al. Scorbutic and fasted guinea pig sera contain an insulin-like growth factor I-reversible inhibitor of proteoglycan and collagen synthesis in chick embryo chondrocytes and adult human skin fibroblasts. Arch Biochem Biophys 1990;276:85-93.
70. Elgin RG, Busby Jr. WH, Clemmons DR. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA 1987;84:3254-8.
71. Gillery P, Leperre A, Maquart FX, et al. Insulin-like growth factor-1 (IGF-I) stimulates protein synthesis and collagen gene expression in monolayer and lattice cultures of fibroblasts. J Cell Physiol 1992;152:389-96.
72. Giudice LC, Dsupin BA, De las Fuentes L, et al. Insulin-like growth factor binding proteins in sera of pregnant nonhuman primates. Endocrinology 1993;132:1514-26.
73. Weed JC, Arquembourg PC. Endometriosis: can it produce an autoimmune response resulting in infertility? Clin Obstet Gynecol 1980;23:885-93.
74. Mathur S, Peress MR, Williamson HO, et al. Autoimmunity to endometrium and ovary in endometriosis. Clin Exp Immunol 1982;50:259-66.
75. Kennedy SH, Starkey PM, Sargent IL, et al. Antiendometrial antibodies in endometriosis measured by an enzyme-linked immunosorbent assay before and after treatment with danazol and nafarelin. Obstet Gynecol 1990;75:914-7.
76. Iborra A, Palacio JR, Ulcova-Gallova Z, et al. Autoimmune response in women with endometriosis. Am J Reprod Immunol 2000;44:236-41.
77. Wild RA, Hirisave V, Podczaski ES, et al. Autoantibodies associated with endometriosis: can their detection predict presence of the disease? Obstet Gynecol 1991;77:927-31.
78. Gleicher N, el-Roeiy A, Confino E, et al. Is endometriosis an autoimmune disease? Obstet Gynecol 1987;70:115-22.
79. Shanti A, Santanam N, Morales AJ, et al. Autoantibodies to markers of oxidative stress are elevated in women with endometriosis. Fertil Steril 1999;71:1115-8.
80. Badawy SZ, Cuenca V, Kaufman L, et al. The regulation of immunoglobulin production by B cells in patients with endometriosis. Fertil Steril 1989;51:770-3.
81. Dmowski WP, Rana N, Michalowska J, et al. The effect of endometriosis, its stage and activity, and of autoantibodies on in vitro fertilization and embryo transfer success rates. Fertil Steril 1995;63:555-62.
82. Kim CH, Chae HD, Kang BM, et al. The immunotherapy during in vitro fertilization and embryo transfer cycles in infertile patients with endometriosis. J Obstet Gynaecol Res 1997;23:463-70.
83. D'Hooghe TM, Hill JA, Oosterlynck DJ, et al. Effect of endometriosis on white blood cell subpopulations in peripheral blood and peritoneal fluid of baboons. Hum Reprod 1996;11: 1736-40.
84. Grosskinsky CM, Halme J. Endometriosis: the host response. Baillieres Clin Obstet Gynaecol 1993;7:701-13.
85. Braun DP, Dmowski WP. Endometriosis: abnormal endometrium and dysfunctional immune response. Curr Opin Obstet Gynecol 1998;10:365-9.
86. Oosterlynck D, Meuleman C, Sobis H, et al. Angiogenic activity of peritoneal fluid from women with endometriosis. Fertil Steril 1993;59:778-82.
87. Ho HN, Wu MY, Yang YS. Peritoneal cellular immunity and endometriosis. Am J Reprod Immunol 1997;38:400-12.
88. Kanzaki H, Wang HS, Kariya M, et al. Suppression of natural killer cell activity by sera from patients with endometriosis. Am J Obstet Gynecol 1992;167:257-61.
89. Garzetti GG, Ciavattini A, Provinciali M, et al. Natural killer activity in stage III and IV endometriosis: impaired cytotoxicity and retained lymphokine responsiveness of natural killer cells. Gynecol Endocrinol 1995;9:125-30.
90. Homung D, Fujii E, Lim KH, et al. Histocompatibility leukocyte antigen-G is not expressed by endometriosis or endometrial tissue. Fertil Steril 2001;75:814-7.
91. Mazzeo D, Vigano P, Di Blasio AM, et al. Interleukin-12 and its free p40 subunit regulate immune recognition of endometrial cells: potential role in endometriosis. J Clin Endocrinol Metab 1998;83:911-6.
92. McLaren J, Dealtry G, Prentice A, et al. Decreased levels of the potent regulator of monocyte/ macrophage activation, inteleukin-13, in the peritoneal fluid of patients with endometriosis. Hum Reprod 1997;12:1307-10.
93. Garcia-Velasco JA, Arici A, Zreik T, et al. Macrophage derived growth factors modulate Fas ligand expression in cultured endometrial stromal cells: a role in endometriosis. Mol Hum Reprod 1999;5:642-50.